Safety and Efficacy of Epelsiban in the Treatment of Men with Premature Ejaculation: A Randomized, Double‐Blind, Placebo‐Controlled, Fixed‐Dose Study

Epelsiban 50 mg and 150 mg were well tolerated, but did not result in a clinically or statistically significant change in IELT in men with PE, compared with placebo. Shinghal R, Barnes A, Mahar KM, Stier B, Giancaterino L, Condreay LD, Black L, and McCallum SW. Safety and efficacy of epelsiban in the treatment of men with premature ejaculation: A randomized, double‐blind, placebo‐controlled, fixed‐dose study. J Sex Med 2013;10:2506-2517.